Images List Premium Download Classic

Infectious Diseases

Infectious Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Biometric disease growth prediction
International Business Machines Corporation
June 14, 2018 - N°20180165419

Embodiments include methods, systems and computer program products for patterning and predicting the growth of infectious diseases through analysis of portable objects. Aspects include receiving biometric data from a plurality of nodes.
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or ...
Curevac Ag
June 14, 2018 - N°20180161422

The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a pathogenic antigen or a fragment, variant or derivative thereof, at least one histone stem-loop and a poly(a) sequence or a polyadenylation signal. Furthermore the present invention provides the use of the nucleic acid for ...
Compositions and conjugates comprising an interleukin and polypeptides that specifically bind tgf-beta
Children's Healthcare Of Atlanta, Inc.
June 07, 2018 - N°20180155439

This disclosure relates to compositions and conjugates comprising an interleukin, e.g., il-15 and a polypeptide that specifically binds tgf-beta. Typically the polypeptide that specifically binds tgf-beta is a type ii tgf-beta receptor.
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel proteins specific for cd137
Pieris Pharmaceuticals Gmbh
May 31, 2018 - N°20180148484

The present disclosure provides human lipocalin muteins that bind cd137 and can be used in pharmaceutical applications, for example, as anti-cancer agents and/or immune modulators for the treatment or prevention of human diseases such as cancer, infectious diseases, and autoimmune diseases. The present disclosure also concerns methods of making cd137 binding lipocalin muteins described herein as well as compositions ...
Methods and compositions for the activation of gamma-delta t-cells
American Gene Technologies International Inc.
May 24, 2018 - N°20180142258

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta t-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.. .
Methods and compositions for the activation of gamma-delta t-cells
American Gene Technologies International Inc.
May 24, 2018 - N°20180142257

The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta t-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.. .
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Targeted nanocarriers for targeted drug delivery of gene therapeutics
Rodos Biotarget Gmbh
May 24, 2018 - N°20180140717

A targeted nanocarriers also termed nanomedicines and methods of preferentially, or actively, targeting and delivering a tool for gene transfer or genome editing (i.e., a plasmid or a restriction enzyme such as a zinc finger nuclease, a crispr/cas system, or a talen) or a tool for gene silencing or post-transcriptional regulation of gene expression (i.e., a microrna, ...
Novel compounds
May 24, 2018 - N°20180140695

Wherein r1 is n-c4-6alkyl or c1-2alkoxyc1-2alkyl-; r2 is hydrogen or methyl; each r3 is hydroxy, halo or n-c1-3alkyl; m is an integer having a value of 2 to 4; n is an integer having a value of 0 to 3; and p is an integer having a value of 0 to 2, are inducers of human interferon. Compounds ...
Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious ...
National University Of Singapore
May 17, 2018 - N°20180135016

The invention provides a chimeric receptor comprising nkg2d, dap10 and cd3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of nk cells.
Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious ...
National University Of Singapore
May 17, 2018 - N°20180135015

The invention provides a chimeric receptor comprising nkg2d, dap10 and cd3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of nk cells.
Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious ...
National University Of Singapore
May 17, 2018 - N°20180135014

The invention provides a chimeric receptor comprising nkg2d, dap10 and cd3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of nk cells.
Chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious ...
National University Of Singapore
May 17, 2018 - N°20180135013

The invention provides a chimeric receptor comprising nkg2d, dap10 and cd3 zeta. Also disclosed is a composition comprising this chimeric receptor and methods for making and using it to enhance the cytotoxicity and antitumor capacity of nk cells.
Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof
Albany Molecular Research, Inc.
May 17, 2018 - N°20180134724

The present invention relates to methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof. The resulting products are useful in the treatment of proliferative diseases and infectious diseases..
Infectious Diseases Patent Pack
Download 108+ patent application PDFs
Infectious Diseases Patent Applications
Download 108+ Infectious Diseases-related PDFs
For professional research & prior art discovery
inventor
  • 108+ full patent PDF documents of Infectious Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Nanoparticle conjugates and uses thereof
Massachusetts Institute Of Technology
May 17, 2018 - N°20180133343

The targeted delivery of therapeutic agents to specific cells remains a challenge in drug delivery. Provided herein are nanoparticle-targeting agent conjugates that can be used for the targeted delivery of therapeutic agents to certain cells and target tissues.
Cell penetrating peptides and complexes comprising the same
Amal Therapeutics Sa
May 17, 2018 - N°20180133327

The present invention provides a cell penetrating peptide derived from zebra, which is optionally linked to a cargo molecule, such as at least one antigen or antigenic epitope. The present invention also provides a complex comprising the cell penetrating peptide and the cargo molecule.
Versatile influenza virus vaccine composition
Korea Research Institute Of Bioscience And Biotechnology
May 17, 2018 - N°20180133305

The present invention relates to a versatile influenza virus vaccine composition using the ha2 helical domain of a hemagglutinin protein, which is an influenza surface protein, and to a pharmaceutical composition for preventing or treating influenza virus infectious diseases. The polypeptide expressed by seq id no: 3 and the polypeptide expressed by residues 379 to 474 of seq id no: 1 of the present ...
A novel complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist
Amal Therapeutics Sa
May 17, 2018 - N°20180133295

The present invention provides a novel complex comprising a) a cell penetrating peptide, b) at least one antigen or antigenic epitope, and c) at least one tlr peptide agonist, wherein the components a)-c) are covalently linked. Moreover, the present invention also provides a nucleic acid encoding such a complex, wherein the complex is a peptide or a protein.
Tenofovir monobenzyl ester phosphamide prodrug, preparation method and use thereof
May 10, 2018 - N°20180127445

The present invention relates to a tenofovir monobenzyl ester phosphamide prodrug, preparation method and pharmaceutical use thereof. Specifically, the present invention relates to a compound of general formula (x), or isomer, pharmaceutically-acceptable salt, hydrate or solvate thereof, preparation method and use thereof in the preparation of drugs for treating viral infectious diseases, preferably aids infection, hepatitis b or diseases caused ...
Modified gamma delta t cells and uses thereof
Tc Biopharm Ltd
May 10, 2018 - N°20180125889

The present invention provides composition and methods for the treatment of cancer or infectious diseases in a human. The invention includes the generation and administration of gamma delta t cells that express chimeric antigen receptors (cars) comprising an antigen binding domain, a hinge domain, a transmembrane domain, a costimulatory signalling domain with the inclusion or not of a cd3 zeta ...
Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumor immunity
The Methodist Hospital
May 03, 2018 - N°20180117176

Porous silicon (psi) microparticles (psm) are disclosed, which provide an important advance in the area of cancer immunotherapeutics and molecular nanomedicine. In particular, potent psm-based adjuvants are disclosed for dendritic cell-based vaccines compositions, and methods for their use in a variety of cancer immunotherapies.
6-amino-purin-8-one compounds
May 03, 2018 - N°20180117048

Wherein r1 is c1-6alkylamino, c1-6alkoxy, or c3-7cycloalkyloxy; m is an integer having a value of 3 to 6; n is an integer having a value of 0 to 4; and salts thereof are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases ...
Loading